A focused newsletter on drug approvals and trial readouts, for people who work in pharma
Daily
Drug approvals and trial results, every day: regulatory decisions, clinical trial readouts, the advisory committee calendar, and deals tied to a specific programme. For people who work in pharma, not stock commentary or consumer wellness content.
Not stock price commentary with no trial or approval news behind it, not consumer health advice aimed at patients, not wellness and supplement marketing, not unverified rumours before a company or regulator confirms them.
Where the news comes from: Endpoints News, FDA press announcements, The European Medicines Agency, Fierce Pharma, BioPharma Dive.
Nobody gets this one yet. It starts when you do.